Remove 2024 Remove Heart attacks Remove Peripheral Arterial Disease
article thumbnail

Anthos Presents New Analysis from P2 AZALEA-TIMI 71 Study

DAIC

tim.hodson Mon, 11/18/2024 - 10:55 Nov. Patient Demographics: Patients on APT had a higher rate of coronary artery disease (70% vs. 42%), previous heart attacks (36% vs. 16%), and peripheral artery disease (15% vs. 11%). For more information, please visit anthostherapeutics.com.

article thumbnail

AI Measures Fat Around the Heart, a Key to Predicting Heart Attacks

DAIC

The global burden of peripheral artery disease. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Heart Assoc. The global burden of peripheral artery disease. J Vasc Surg. 2023;77:1119-26. J Am Coll Card.

article thumbnail

Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter

DAIC

tim.hodson Mon, 09/16/2024 - 10:49 Sept. 16, 2024 – Shockwave Medical, Inc., launch of the Shockwave E 8 Peripheral IVL Catheter, following clearance by the U.S. 1 People suffering from PAD have not only impaired quality of life but also increased risk of heart attack or stroke.

article thumbnail

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

article thumbnail

Johnson and Johnson to Acquire Shockwave Medical

DAIC

Getty Images milla1cf Fri, 04/05/2024 - 09:57 April 5, 2024 — Johnson & Johnson and Shockwave Medical , Inc. IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heart attack. in 2024 and approximately $0.17

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

article thumbnail

Society for Vascular Surgery Launches Campaign to Help People Maintain Vascular Health

DAIC

tim.hodson Wed, 10/23/2024 - 13:54 Oct. According to a recent survey released today by the Society, nearly one in three Americans at the highest risk for developing blood vessel (vascular) diseases have not heard of any of the most common conditions, like peripheral artery disease and carotid artery disease.